Cargando…
Discovery of a drug to treat airway mucus hypersecretion
Autores principales: | Dickey, Burton F., Lai, Ying, Frick, Manfred, Brunger, Axel T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339237/ https://www.ncbi.nlm.nih.gov/pubmed/35908252 http://dx.doi.org/10.1002/ctm2.972 |
Ejemplares similares
-
Airway Mucus Dysfunction in COVID-19
por: Dickey, Burton F., et al.
Publicado: (2022) -
Association of the CFTR gene with asthma and airway mucus hypersecretion
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2021) -
Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
por: Shimizu, Takeshi, et al.
Publicado: (2012) -
PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases
por: Shen, Yongchun, et al.
Publicado: (2012) -
Mucus Hypersecretion and Ciliary Impairment in Conducting Airway Contribute to Alveolar Mucus Plugging in Idiopathic Pulmonary Fibrosis
por: Peng, Yang, et al.
Publicado: (2022)